How Many Seniors Will Needlessly Be Left to Die Before This Coronavirus Pandemic Is Over?

By Jim Hoft and Nick Mastrangelo

On December 15th my dear friend Eric found out he had contracted coronavirus at his nursing home.  Eric was kept in isolation in his assisted living apartment since March when the pandemic made its way to the US despite the historic efforts by the American president.   But after nine months there was an outbreak at his nursing home and Eric caught the virus.

Eric was 81-years-old, he was overweight, diabetic, and was suspected of having Parkinson’s Disease.  Eric was in poor health and declining before the virus, he was the exact type of person you would want to protect from this virus that is lethal for seniors and less lethal than the seasonal flu with children and young adults.

When I spoke with Eric he said he felt fine.  I asked him what medications he was on since his diagnosis with the coronavirus.  I asked him if he was on any prophylactics to assist his recovery from the virus.  Eric said their plan was to wait and see.  The nursing home did not give ANY medications for coronavirus unless the patient starts to experience symptoms.

This shocked me.  How could it be that after nine months and over 300,000 related deaths (at that time) that the medical community had NOTHING for seniors and the obese to help them before the disease could advance and take their life?

Two weeks later when I returned from a trip I heard Eric’s condition had worsened.  A day later they put Eric in the hospital.  And two days later, on December 31, my dear friend Eric Junger died.  He was 81.

* * * * * * * * * *

It’s been over a year since the WHO declared the coronavirus a pandemic after originally downplaying the viral threat.  It is no secret that both the disease and the response to combat it following this SARS-CoV-2 outbreak in late 2019 have turned our world upside-down.  Mandates, lockdowns, and guidelines seem to change every time Dr. Fauci opens his mouth.   All of these unprecedented rules were put into place, we were told, to stop the spread of a disease that today is linked to the death of over half a million Americans in just over a year.

You would think that a disease that is a death sentence for the elderly, the obese, those with preexisting conditions, and that has forced children to avoid school, mask up, and get vaccinated would have certainly been faced with ramped-up research into prophylactic and therapeutic solutions since its arrival to the United States.  One would think that after all this time there would be a consensus in the hospitals, in the nursing homes, and in other treatment centers on how to treat a Covid positive patient or resident.  This is not the case.

Although the FDA provides a list of therapeutics and drugs approved under the EUA, there is still many discrepancies regarding the plan of action taken between hospital to hospital, or center to center.  Local New York doctors have even strayed from the list provided by the FDA and administered a drug called Ivermectin to treat their Covid positive patients.  Although Ivermectin is not yet approved by the FDA to treat Covid-19, Dr. Paul Shields of New York states that since December, the drug successfully treated 80 out of his 90 nursing home residents.

During the past year, we have also seen political biases coming between pursuing other possible treatments like Hydroxychloroquine.  Dr. Fauci, the media and the American medical community shot down its effectiveness last year.

Today over 231 clinical trials have been published on the effectiveness of hydroxychloroquine on the coronavirus.  Using hydroxychloroquine in early treatment, before a patient becomes deathly ill, shows significant improvement according to the studies listed at c19HCQ.com.   Yet many doctors still frown on administering the drug to patients as a prophylactic or in early treatment.  Why is this?

Medical studies also show zinc and Vitamin D could have protective effects against COVID19 by supporting anti-viral immunity and reducing inflammation.  Why are these not in an early diagnosis treatment plan?

What exactly is going on here?

Recently, The Gateway Pundit called a state Public Health Department and a county Public Health Department to ask about their early treatment plan for patients with the coronavirus.  What we found is that the details on specific plans of action are either unknown or unavailable.  Calling the hospitals themselves resulted in impatient phone operators who “don’t have time” for the caller, or a wild goose chase being sent from line to line and eventually getting hung up on.  Few nursing homes have proven to be very informative on what they do when staff or resident tests positive for Covid. However, treatment for the patient is still primarily at the discretion of the doctor or nurse practitioner with Dexamethasone being a standard option for pneumonia-like symptoms in covid patients.  Because nursing homes do not carry the vast assortment of treatments that a hospital might, most of these residents are transferred to the hospital when they are ill.

It is a travesty that the US medical community still does not have a consensus plan of action for early treatment of coronavirus patients.  How many seniors could have been saved but were left to die because there is no early treatment plan. 

It really makes you wonder how many lives could have been saved?

And it makes me wonder if my friend Eric would still be here with us.

UPDATE: From a reader —Intervectim is another drug that has shown success but it is ignored by the American Medical Community that continues to fail the nation.

At a March 18, 2021 press conference, a group of medical and scientific experts convened by the Front Line COVID-19 Critical Care Alliance (FLCCC) called for action to put an end to the COVID-19 pandemic by immediately adopting policies that allow for the use of ivermectin in the prevention and treatment of COVID-19.

Scientists and physicians from the U.S., U.K., E.U., South America, and Israel gathered to discuss the latest data on how ivermectin has reduced positive COVID-19 cases in major cities across the world, ivermectin’s role in the early treatment of COVID-19, and why ivermectin needs to be adopted as safe and effective prevention and treatment of COVID-19.

Photo of author
Jim Hoft is the founder and editor of The Gateway Pundit, one of the top conservative news outlets in America. Jim was awarded the Reed Irvine Accuracy in Media Award in 2013 and is the proud recipient of the Breitbart Award for Excellence in Online Journalism from the Americans for Prosperity Foundation in May 2016. In 2023, The Gateway Pundit received the Most Trusted Print Media Award at the American Liberty Awards.

You can email Jim Hoft here, and read more of Jim Hoft's articles here.

 

Thanks for sharing!